XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Description Of The Business
3 Months Ended
Mar. 31, 2019
Description Of The Business [Abstract]  
Description Of The Business

1.  Description of the Business



Pulse Biosciences, Inc., is a bioelectric medicine company pursuing commercial introduction of its proprietary CellFX™ System utilizing the Company’s proprietary Nano-Pulse Stimulation™ (NPS™) platform technology. The Company’s NPS technology provides a novel, precise, non-thermal cellular treatment technology delivering nanosecond pulses of high amplitude electrical energy that clear targeted cells while sparing adjacent non-cellular tissue. The novel characteristics of the Company’s NPS mechanism of action has the potential to significantly benefit patients across multiple medical applications, including dermatology, the Company’s first planned commercial application.

The Company was incorporated in Nevada on May 19, 2014. On June 18, 2018, the Company reincorporated from the State of Nevada to the State of Delaware. The Company’s headquarters and research facility are located in Hayward, California.

The Company’s activities are subject to significant risks and uncertainties, including the need for additional capital. The Company has not yet commenced revenue-generating operations, does not have cash flows from operations, and will need to raise additional capital to finance its operations. There can be no assurances that the Company will be able to obtain additional financing on acceptable terms and in the amounts necessary to fully fund its operating requirements.